SAN CARLOS, Calif. & LISBON, Portugal--March 7, 2024--CuraSen Therapeutics, Inc., a clinical-stage company developing small molecule therapies to treat neurodegenerative disease, announced that it will present additional positive Phase 2a...
Art Pappas to sit on a panel titled "Venture Funding" at the EDC BioTech 2008 conference at in Miami, FL
News | 04. 24. 2008
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.